Pharmacometrics Can Guide Further Trials, Minimize Risks – FDA Analysis
Executive Summary
Pharmacometric analysis can be used to refine the design of further studies following failed clinical trials, according to an analysis by reviewers in FDA's Office of Clinical Pharmacology & Biopharmaceutics